These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

346 related articles for article (PubMed ID: 31547939)

  • 1. Kidney Biomarkers of Injury and Repair as Predictors of Contrast-Associated AKI: A Substudy of the PRESERVE Trial.
    Parikh CR; Liu C; Mor MK; Palevsky PM; Kaufman JS; Thiessen Philbrook H; Weisbord SD
    Am J Kidney Dis; 2020 Feb; 75(2):187-194. PubMed ID: 31547939
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Postangiography Increases in Serum Creatinine and Biomarkers of Injury and Repair.
    Liu C; Mor MK; Palevsky PM; Kaufman JS; Thiessen Philbrook H; Weisbord SD; Parikh CR
    Clin J Am Soc Nephrol; 2020 Sep; 15(9):1240-1250. PubMed ID: 32839195
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Biomarkers of Kidney Tubule Health, CKD Progression, and Acute Kidney Injury in SPRINT (Systolic Blood Pressure Intervention Trial) Participants.
    Bullen AL; Katz R; Jotwani V; Garimella PS; Lee AK; Estrella MM; Shlipak MG; Ix JH
    Am J Kidney Dis; 2021 Sep; 78(3):361-368.e1. PubMed ID: 33857535
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Strategies to Reduce Acute Kidney Injury and Improve Clinical Outcomes Following Percutaneous Coronary Intervention: A Subgroup Analysis of the PRESERVE Trial.
    Garcia S; Bhatt DL; Gallagher M; Jneid H; Kaufman J; Palevsky PM; Wu H; Weisbord SD;
    JACC Cardiovasc Interv; 2018 Nov; 11(22):2254-2261. PubMed ID: 30466822
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prevention of contrast-induced AKI: a review of published trials and the design of the prevention of serious adverse events following angiography (PRESERVE) trial.
    Weisbord SD; Gallagher M; Kaufman J; Cass A; Parikh CR; Chertow GM; Shunk KA; McCullough PA; Fine MJ; Mor MK; Lew RA; Huang GD; Conner TA; Brophy MT; Lee J; Soliva S; Palevsky PM
    Clin J Am Soc Nephrol; 2013 Sep; 8(9):1618-31. PubMed ID: 23660180
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Urinary Biomarkers and Kidney Injury in VA NEPHRON-D: Phenotyping Acute Kidney Injury in Clinical Trials.
    Kiernan EA; Hu D; Philbrook HT; Ix JH; Bonventre JV; Coca SG; Moledina DG; Fried LF; Shlipak MG; Parikh CR
    Am J Kidney Dis; 2024 Feb; 83(2):151-161. PubMed ID: 37726051
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Sodium bicarbonate plus N-acetylcysteine prophylaxis: a meta-analysis.
    Brown JR; Block CA; Malenka DJ; O'Connor GT; Schoolwerth AC; Thompson CA
    JACC Cardiovasc Interv; 2009 Nov; 2(11):1116-24. PubMed ID: 19926054
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Biomarkers in the prediction of contrast media induced nephropathy - the BITCOIN study.
    Seibert FS; Heringhaus A; Pagonas N; Rudolf H; Rohn B; Bauer F; Timmesfeld N; Trappe HJ; Babel N; Westhoff TH
    PLoS One; 2020; 15(7):e0234921. PubMed ID: 32673348
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Subclinical and clinical contrast-induced acute kidney injury: data from a novel blood marker for determining the risk of developing contrast-induced nephropathy (ENCINO), a prospective study.
    Akrawinthawong K; Ricci J; Cannon L; Dixon S; Kupfer K; Stivers D; Alexander P; David S; McCullough PA
    Ren Fail; 2015 Mar; 37(2):187-91. PubMed ID: 25519207
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Outcomes after Angiography with Sodium Bicarbonate and Acetylcysteine.
    Weisbord SD; Gallagher M; Jneid H; Garcia S; Cass A; Thwin SS; Conner TA; Chertow GM; Bhatt DL; Shunk K; Parikh CR; McFalls EO; Brophy M; Ferguson R; Wu H; Androsenko M; Myles J; Kaufman J; Palevsky PM;
    N Engl J Med; 2018 Feb; 378(7):603-614. PubMed ID: 29130810
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Do intravenous N-acetylcysteine and sodium bicarbonate prevent high osmolal contrast-induced acute kidney injury? A randomized controlled trial.
    Inda-Filho AJ; Caixeta A; Manggini M; Schor N
    PLoS One; 2014; 9(9):e107602. PubMed ID: 25254489
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Renal insufficiency following contrast media administration trial II (REMEDIAL II): RenalGuard system in high-risk patients for contrast-induced acute kidney injury: rationale and design.
    Briguori C; Visconti G; Ricciardelli B; Condorelli G;
    EuroIntervention; 2011 Apr; 6(9):1117-22, 7. PubMed ID: 21518686
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Kidney Cell Cycle Arrest and Cardiac Biomarkers and Acute Kidney Injury Following Angiography: The Prevention of Serious Adverse Events Following Angiography (PRESERVE) Study.
    Murugan R; Boudreaux-Kelly MY; Kellum JA; Palevsky PM; Weisbord S;
    Kidney Med; 2023 Mar; 5(3):100592. PubMed ID: 36874509
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Variation in contrast-associated acute kidney injury prophylaxis for percutaneous coronary intervention: insights from the Veterans Affairs Clinical Assessment, Reporting, and Tracking (CART) program.
    Keach JW; Stanislawski MA; Barón AE; Plomondon ME; Langner P; Amin A; Gilmartin HM; Waldo S; Maddox TM
    BMC Nephrol; 2020 Apr; 21(1):150. PubMed ID: 32345254
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Neutrophil Gelatinase-Associated Lipocalin and Contrast-Induced Acute Kidney Injury.
    Quintavalle C; Anselmi CV; De Micco F; Roscigno G; Visconti G; Golia B; Focaccio A; Ricciardelli B; Perna E; Papa L; Donnarumma E; Condorelli G; Briguori C
    Circ Cardiovasc Interv; 2015 Sep; 8(9):e002673. PubMed ID: 26333343
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Accuracy of neutrophil gelatinase-associated lipocalin (NGAL) in diagnosis and prognosis in acute kidney injury: a systematic review and meta-analysis.
    Haase M; Bellomo R; Devarajan P; Schlattmann P; Haase-Fielitz A;
    Am J Kidney Dis; 2009 Dec; 54(6):1012-24. PubMed ID: 19850388
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Neutrophil gelatinase-associated lipocalin (NGAL) for the early detection of contrast-induced nephropathy after percutaneous coronary intervention.
    Liebetrau C; Gaede L; Doerr O; Blumenstein J; Rixe J; Teichert O; Willmer M; Weber M; Rolf A; Möllmann H; Hamm C; Nef H
    Scand J Clin Lab Invest; 2014 Mar; 74(2):81-8. PubMed ID: 24304491
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prevention of contrast-induced acute kidney injury in patients with stable chronic renal disease undergoing elective percutaneous coronary and peripheral interventions: randomized comparison of two preventive strategies.
    Hafiz AM; Jan MF; Mori N; Shaikh F; Wallach J; Bajwa T; Allaqaband S
    Catheter Cardiovasc Interv; 2012 May; 79(6):929-37. PubMed ID: 21542114
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Urinary kidney injury molecule-1 and monocyte chemotactic protein-1 are noninvasive biomarkers of cisplatin-induced nephrotoxicity in lung cancer patients.
    Shinke H; Masuda S; Togashi Y; Ikemi Y; Ozawa A; Sato T; Kim YH; Mishima M; Ichimura T; Bonventre JV; Matsubara K
    Cancer Chemother Pharmacol; 2015 Nov; 76(5):989-96. PubMed ID: 26407820
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of combination therapy of high-dose oral N-acetylcysteine and intravenous sodium bicarbonate hydration with individual therapies in the reduction of Contrast-induced Nephropathy during Cardiac Catheterisation and Percutaneous Coronary Intervention (CONTRAST): A multi-centre, randomised, controlled trial.
    Chong E; Poh KK; Lu Q; Zhang JJ; Tan N; Hou XM; Ong HY; Azan A; Chen SL; Chen JY; Ali RM; Fang WY; Lau TW; Tan HC
    Int J Cardiol; 2015 Dec; 201():237-42. PubMed ID: 26301645
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.